Teva-MedinCell Alliance Heats Up With Second Phase III Trial Underway

Studies Begin For Proposed First Subcutaneous LAI Formulation Of Olanzapine

 
• By Dean Rudge
3D illustration of files with schizophrenia diagnosis and treatment with antipsychotic medication and psychotherapy.
Invega and Risperdal Consta dominate the market • Source: Alamy

More from Value Added Medicines

More from Products